| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6191438 | European Journal of Surgical Oncology (EJSO) | 2015 | 9 Pages |
Abstract
1, 2, 3 and 5-year overall survival is increased by CC0-CC1 cytoreduction in patients with PC from gastric origin. Moreover CC0 increases the 1 and 3 years survival when compared to CC1 cytoreduction.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
F. Coccolini, F. Catena, O. Glehen, Y. Yonemura, P.H. Sugarbaker, P. Piso, G. Montori, L. Ansaloni,